HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Manto Selected Research

Glutens (Glutelin)

4/2024Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.
11/2023Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.
8/2022Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
1/2022Pharmacotherapy of cerebellar and vestibular disorders.
1/2021Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
1/2019Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
8/2018Time Is Cerebellum.
1/2017Immune-mediated cerebellar ataxias: from bench to bedside.
4/2016Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Manto Research Topics

Disease

28Cerebellar Ataxia (Dysmetria)
11/2023 - 01/2008
21Ataxia (Dyssynergia)
04/2024 - 08/2009
11Cerebellar Diseases (Cerebellar Syndrome)
07/2023 - 09/2009
7Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
04/2024 - 01/2019
6Paraneoplastic Cerebellar Degeneration
04/2024 - 04/2016
5Tremor (Tremors)
01/2014 - 01/2007
4Multiple Sclerosis
04/2024 - 08/2018
4Miller Fisher Syndrome (Fisher Syndrome)
04/2024 - 04/2016
4Stroke (Strokes)
12/2022 - 01/2017
4Movement Disorders (Movement Disorder)
12/2022 - 04/2007
3Neoplasms (Cancer)
11/2023 - 01/2017
3Nervous System Diseases (Neurological Disorders)
06/2022 - 01/2015
3Friedreich Ataxia (Friedreich's Ataxia)
01/2022 - 04/2010
3Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
01/2021 - 01/2015
3Stiff-Person Syndrome (Stiff Man Syndrome)
10/2018 - 06/2013
3Spinocerebellar Ataxias (Spinocerebellar Ataxia)
10/2016 - 06/2009
3Encephalitis (Encephalitis, Rasmussen)
06/2016 - 11/2010
3Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
10/2013 - 08/2009
2Behcet Syndrome (Behcet's Syndrome)
04/2024 - 11/2023
2Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
04/2024 - 11/2023
2Infections
11/2023 - 08/2020
2Type 2 Episodic Ataxia
01/2022 - 04/2020
2Disease Progression
12/2019 - 01/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018 - 01/2015
2Essential Tremor (Essential Tremors)
06/2016 - 04/2007
1Inflammation (Inflammations)
01/2022
1Meniere Disease (Menieres Disease)
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2022
1Benign Paroxysmal Positional Vertigo
01/2022
1Alcoholism (Alcohol Abuse)
01/2021
1Neuroinflammatory Diseases
01/2021
1Fetal Alcohol Spectrum Disorders
01/2021
1Thiamine Deficiency
01/2021
1Leukocytosis (Pleocytosis)
08/2020
1Cytokine Release Syndrome
08/2020
1Autoimmune Diseases (Autoimmune Disease)
08/2020
1Leukoencephalopathies
01/2019
1Adenocarcinoma
01/2019
1Brain Diseases (Brain Disorder)
12/2018

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
08/2023 - 11/2010
9Glutens (Glutelin)IBA
04/2024 - 04/2016
6AutoantibodiesIBA
07/2020 - 06/2013
5Proteins (Proteins, Gene)FDA Link
02/2023 - 07/2020
5EpitopesIBA
10/2018 - 06/2013
4Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
04/2024 - 01/2015
4Biomarkers (Surrogate Marker)IBA
08/2023 - 08/2020
3Ion Channels (Ion Channel)IBA
08/2022 - 07/2020
3RNA (Ribonucleic Acid)IBA
01/2021 - 12/2009
3Protein Isoforms (Isoforms)IBA
10/2018 - 06/2013
3N-Methylaspartate (NMDA)IBA
06/2016 - 11/2010
2CollagenIBA
04/2024 - 11/2023
2AntigensIBA
08/2022 - 01/2019
2metabotropic glutamate receptor type 1IBA
02/2022 - 01/2021
2Glutamate Receptors (Glutamate Receptor)IBA
02/2022 - 01/2021
2Carboxy-LyasesIBA
01/2022 - 01/2019
24-Aminopyridine (4 Aminopyridine)FDA Link
01/2022 - 04/2020
2Ethanol (Ethyl Alcohol)IBA
01/2021 - 01/2018
2AntioxidantsIBA
01/2019 - 04/2010
2salicylhydroxamic acid (SHAM)IBA
12/2018 - 01/2014
2EnzymesIBA
10/2018 - 04/2010
2SaltsIBA
01/2018 - 01/2012
2Heroin (Diamorphine)IBA
01/2018 - 01/2012
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 01/2012
2LithiumIBA
01/2018 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
10/2016 - 10/2013
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2011 - 11/2010
1Glial Fibrillary Acidic ProteinIBA
04/2024
1Complement System Proteins (Complement)IBA
06/2022
1Betahistine (Serc)IBA
01/2022
1acetylleucineIBA
01/2022
1Acetazolamide (Diamox)FDA LinkGeneric
01/2022
1AcidsIBA
01/2022
1omaveloxoloneIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1SteroidsIBA
01/2022
1Vitamin DFDA LinkGeneric
01/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2020
1Oligoclonal BandsIBA
08/2020
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
07/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
1Leucovorin (Folinic Acid)FDA Link
01/2019
1AminopyridinesIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019

Therapy/Procedure

18Therapeutics
11/2023 - 04/2007
6Transcranial Direct Current Stimulation
12/2022 - 01/2008
3Orthotic Devices (Orthosis)
06/2015 - 01/2007
2Gluten-Free Diet
01/2022 - 01/2019
2Drug Therapy (Chemotherapy)
01/2019 - 01/2013
2Injections
11/2017 - 06/2016
2Brain-Computer Interfaces
01/2013 - 01/2010
1Secondary Prevention
08/2022
1Operative Surgical Procedures
06/2021
1Endovascular Procedures
06/2021
1Craniotomy
06/2021
1Thrombectomy
06/2021
1Occupational Therapy (Therapy, Occupational)
04/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2019
1Transplantation
06/2019